These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9776342

  • 1. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.
    Brixius K, Mohr V, Müller-Ehmsen J, Hoischen S, Münch G, Schwinger RH.
    Br J Pharmacol; 1998 Sep; 125(1):41-8. PubMed ID: 9776342
    [Abstract] [Full Text] [Related]

  • 2. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
    Müller-Ehmsen J, Brixius K, Hoischen S, Schwinger RH.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
    Schwinger RH, Hoischen S, Reuter H, Hullin R.
    J Mol Cell Cardiol; 1999 Jan; 31(1):283-96. PubMed ID: 10072735
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
    Hoischen S, Brixius K, Schwinger RH.
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
    Triggle DJ.
    J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
    [Abstract] [Full Text] [Related]

  • 10. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium.
    Hsu CH, Wei J, Chen YC, Yang SP, Tsai CS, Lin CI.
    J Heart Lung Transplant; 2006 Sep; 25(9):1126-34. PubMed ID: 16962476
    [Abstract] [Full Text] [Related]

  • 11. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G, Lüscher TF.
    Cardiology; 1998 Sep; 89 Suppl 1():10-5. PubMed ID: 9570424
    [Abstract] [Full Text] [Related]

  • 12. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE, Hamlin RL.
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [Abstract] [Full Text] [Related]

  • 13. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
    Cremers B, Flesch M, Südkamp M, Böhm M.
    J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY, Sandmann S, Meissner A, Unger T, Simon R.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [Abstract] [Full Text] [Related]

  • 15. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes.
    Magnon M, Gallix P, Cavero I.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077
    [Abstract] [Full Text] [Related]

  • 16. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
    Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K.
    Pharmacology; 2006 Dec; 78(1):11-20. PubMed ID: 16899990
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
    Aczél S, Kurka B, Hering S.
    Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
    [Abstract] [Full Text] [Related]

  • 18. In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action.
    Osterrieder W, Holck M.
    J Cardiovasc Pharmacol; 1989 May; 13(5):754-9. PubMed ID: 2472524
    [Abstract] [Full Text] [Related]

  • 19. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
    Schwinger RH, Böhm M, Schulz C, Schmidt U, Schmidt U, Schmid B, Dienemann H, Reichart B, Erdmann E.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):346-57. PubMed ID: 8386240
    [Abstract] [Full Text] [Related]

  • 20. Proliferation of human peripheral blood mononuclear cells during calcium channel blockade.
    Lijnen P, Fagard R, Petrov V.
    Am J Hypertens; 1998 Dec; 11(12):1461-8. PubMed ID: 9880128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.